Results 151 to 160 of about 18,821 (231)

Discordance in tests used to detect inhibition of the P2Y12 receptor in patients undergoing interventional neuroradiology procedures. [PDF]

Interv Neuroradiol, 2023
Gegri M, Cheves TA, Anderson MN, McTaggart R, Sweeney JD.   +4 more
europepmc   +1 more source

Postoperative Bleeding Risk after Gastric Endoscopic Submucosal Dissection in Patients Receiving a P2Y12 Receptor Antagonist. [PDF]

Gut Liver, 2023
Hirai R, Kawano S, Inoo S, Kuraoka S, Okanoue S, Satomi T, Hamada K, Kono Y, Kanzaki H, Iwamuro M, Kawahara Y, Okada H.   +11 more
europepmc   +1 more source

P2Y12 Receptor Antagonists and Morphine: A Dangerous Liaison?

, 2016
P2Y12 receptor antagonists, concurrently administered with aspirin in what has come to be commonly called dual antiplatelet therapy, are a mainstay of treatment for patients with acute coronary syndromes.
Deftereos, S., Xanthopoulou, I., Lekakis, J., Giannopoulos, G., Alexopoulos, D., Kolokathis, F.   +5 more
core  

Increased expression of the P2Y₁₂ receptor is involved in the failure of autogenous arteriovenous fistula caused by stenosis. [PDF]

Ren Fail, 2023
Liu L, Gao J, Tang Y, Guo G, Gan H.
europepmc   +1 more source

The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo. [PDF]

J Clin Med, 2021
Crescence L, Kramberg M, Baumann M, Rey M, Roux S, Panicot-Dubois L, Dubois C, Riederer MA.   +7 more
europepmc   +1 more source

A P2Y12 receptor szerkezete és működése: in silico vizsgálatok

, 2013
A G-proteinhez kapcsolt receptorok (GPCR) alapvető fontosságú szerepet töltenek be a szervezet jelátviteli folyamatainak szabályozásában. A gyógyszerkutatás is felismerte jelentőségüket: a jelenlegi gyógyszerhatóanyagok kb.
Bajusz, Dávid
core  

Response to letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]

Cardiol J
Altınkaya O, Aydemir S, Özkoç M.
europepmc   +1 more source

Letter to the Editor regarding: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry. [PDF]

BMC Cardiovasc Disord, 2023
Kang J, Han JK, Yang HM, Park KW, Kang HJ, Koo BK, Choo EH, Lee JY, Park SD, Lim YH, Kim HM, Heo JH, Kim HS.   +12 more
europepmc   +1 more source

Platelet P2Y12 receptor influences the vessel wall response to arterial injury and thrombosis

, 2009
Background— Platelets are believed to play an important role in atherogenesis and the vessel response to vascular injury. The P2Y12 receptor (P2Y12) plays a central role in amplifying platelet aggregation, dense granule and α-granule secretion, P ...
Crosdale, D. J., Francis, S. E., Evans, David, Judge, H. M., Jackman, L. E., Chamberlain, J., Norman, K. E., Jetha, K., Storey, R. F.   +8 more
core